For experiments assessing pMHC-specific CTLs on AML cells, we generated CTLs targeting the HLA-A*02:01-restricted 9 amino acid peptide RMFPNAPYL from the protein WT1. This evidence concerns the gene HLA-A and acute myeloid leukemia.